Table 1. Changes of mRNA expression of mechanistic brain markers of PN4 mouse pups by triple antenatal DEX-treatments.
Postnatal day 4 | ||||
---|---|---|---|---|
Total brain–mRNA expression | ||||
Target | 1x NaCl | 1x DEXl | 3x NaCl | 3x DEX |
Angiogenesis | ||||
VEGF-A | 1.00 ± 0.13 | 0.97 ± 0.19 | 1 ± 0 | 0.48 ± 0.17 $ |
VEGFR2 | 1.00 ± 0.14 | 1.14 ± 0.33 | 1 ± 0 | 0.47 ± 0.13 $ |
Nrp1 | 1.00 ± 0.09 | 1.16 ± 0.23 | 1 ± 0 | 0.37 ± 0.12 $ |
Tie-2 | 1.00 ± 0.15 | 1.20 ± 0.40 | 1 ± 0 | 0.33 ± 0.09 $ |
Angpt1 | 1.00 ± 0.01 | 1.02 ± 0.17 | 1 ± 0 | 0.43 ± 0.17 $ |
Angpt2 | 1.00 ± 0.11 | 1.07 ± 0.22 | 1 ± 0 | 0.37 ± 0.16 $ |
Shh-pathway | ||||
Shh | 1.00 ± 0.007 | 1.12 ± 0.20 | 1 ± 0 | 0.37 ± 0.17 $ |
PTCH1 | 1.00 ± 0.05 | 0.91 ± 0.12 | 1 ± 0 | 0.56 ± 0.25 |
Sox-18 | 1.00 ± 0.05 | 1.28 ± 0.20 | 1 ± 0 | 0.54 ± 0.13 $ |
Wnt-pathway | ||||
Axin-2 | 1.00 ± 0.003 | 0.94 ± 0.19 | 1 ± 0 | 0.45 ± 0.15 $ |
Brain endothelial cells–mRNA expression | ||||
Target | 1x NaCl | 1x DEXl | 3x NaCl | 3x DEX |
Angiogenesis | ||||
VEGF-A | 1.00 ± 0.09 | 2.20 ± 0.25 $ | 1 ± 0 | 0.61 ± 0.13 $ |
VEGFR2 | 1.00 ± 0.17 | 1.92 ± 0.57 | 1 ± 0 | 0.46 ± 0.13 $ |
Nrp1 | 1.00 ± 0.03 | 3.01 ± 0.27 $ | 1 ± 0 | 0.51 ± 0.12 $ |
Tie-2 | 1.00 ± 0.24 | 2.96 ± 0.39 $ | 1 ± 0 | 0.43 ± 0.13 $ |
Angpt1 | 1.00 ± 0.02 | 3.53 ± 0.64 $ | 1 ± 0 | 0.57 ± 0.13 $ |
Angpt2 | 1.00 ± 0.09 | 2.50 ± 0.50 $ | 1 ± 0 | 0.31 ± 0.07 $ |
Shh-pathway | ||||
Shh | 1.00 ± 0.11 | 3.41 ± 0.32 $ | 1 ± 0 | 0.66 ± 0.19 |
PTCH1 | 1.00 ± 0.02 | 2.32 ± 0.13 $ | 1 ± 0 | 0.57 ± 0.13 $ |
Sox-18 | 1.00 ± 0.06 | 2.09 ± 0.24 $ | 1 ± 0 | 0.85 ± 0.36 |
Wnt-pathway | ||||
Axin-2 | 1.00 ± 0.05 | 1.99 ± 0.21 $ | 1 ± 0 | 0.54 ± 0.12 $ |
mRNA expression of mechanistic brain markers of PN4 mouse pups changed by triple antenatal DEX-treatments. Data are presented as the means ± SEM; n = 5–6 biological samples, at PN4 2–3 brains from one litter were pooled to one biological sample, biological samples were collected from at least three different litters
$: p<0.05 after two-tailed Student’s t-test.